NEW DELHI (Reuters) – Pfizer is in discussions with India and committed to make its COVID-19 vaccine available for deployment in the country, the U.S. drugmaker said on Thursday.
The company said it had offered India a not-for-profit price for its vaccine for the government’s immunisation programme.
(Reporting by Krishna Das; Writing by Shilpa Jamkhandikar; Editing by David Goodman)
